seven people died of blood clots after receiving the AstraZeneca vaccine

Seven people died from a syndrome based on rare blood clots after receiving the AstraZeneca vaccine against Covid-19 in the UK.

Regulators have identified 30 cases of rare blood clots after using AstraZeneca’s coronavirus vaccine, 25 more than the Medicines and Health Products Regulatory Agency (MHRA) had already reported, reveals Shimmering.

We do not yet know if this is a coincidence or a real side effect of the vaccine, analyze the specialists in a context where the coronavirus pandemic is not weakening in the world.

Leading health organizations were quick to reassure worried people that the dangers posed little small number regarding the health benefits.

The MHRA, the European Medicines Agency and the World Health Organization (WHO) has ruled that the vaccine’s benefits in preventing Covid-19 far outweigh any possible risk of blood clots.

Paul hunter, professor of medicine at the University of East Anglia, stressed that vaccine-related deaths remain very rare. “The risk of death is still much higher in people who are not vaccinated than in people who have received the vaccine,” he said. The Guardian. “It wouldn’t deter me from my next dose,” he said.

Countries with doubts

Some countries are restrict the use of the AstraZeneca vaccinewhile others have resumed inoculations as investigations into reports of rare and sometimes serious blood clots continue.

For example, Germany, France, the Netherlands and Canada have restricted the use of the vaccine only in the elderly.

The British drug regulator said on March 18 that there were five cases of rare cerebral blood clots among the 11 million injections given.

The calculation changed last Thursday: they estimated 22 reports of cerebral venous sinus thrombosis (CVST), an extremely rare brain coagulation disease, and 8 reports of other coagulation events associated with low platelet counts out of a total of 18.1 million doses administered, the UK portal expands.

A word from the experts

June Raine, Executive Director of the MHRA, said the agency was investigating the reports, but would continue to apply the vaccines using the same argument: “The benefits of the AstraZeneca vaccine in preventing infection with Covid-19 and its complications continue to overcome any risk», He stressed.

According to studies, the nature of the clots found is unusual, with low levels of platelets and rare antibodies found in the blood, which have been linked to other bleeding disorders.

David Werring, professor at the UCL Institute of Neurology, alerted the BBC on the need for “Carry out an urgent investigation” if this disorder implies that the vaccine has a causal relationship with the clots.

As the pandemic continues, researchers are trying to determine how badly the CVST clots, with estimates ranging from two cases per million people each year to almost 16 in a million normally.